Literature DB >> 22189525

Serum procalcitonin value is useful for predicting severity of Kawasaki disease.

Hideki Yoshikawa1, Yuichi Nomura, Kiminori Masuda, Chihaya Koriya, Michiko Arata, Daisuke Hazeki, Kosuke Yanagimoto, Kentaro Ueno, Taisuke Eguchi, Yoshifumi Kawano.   

Abstract

We measured serum procalcitonin concentrations in 160 patients suffering from Kawasaki disease. Serum procalcitonin was significantly higher in nonresponders to an initial intravenous immunoglobulin treatment than in responders. A cutoff value of procalcitonin (0.5 ng/mL) for nonresponders showed that the sensitivity was 85% and the accuracy was 64%. Multivariate logistic regression analysis revealed that procalcitonin-positive cases showed the highest risk for nonresponders.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22189525     DOI： 10.1097/INF.0b013e3182463879

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.

Authors:  Xu Teng; Yang Wang; Nan Lin; Mei Sun; Jie Wu
Journal:  Clin Rheumatol       Date:  2014-10-03       Impact factor: 2.980

2.  Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.

Authors:  Feifei Si; Yao Wu; Fang Gao; Siqi Feng; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2017-01-20       Impact factor: 3.984

3.  A new scoring system for coronary artery abnormalities in Kawasaki disease.

Authors:  Hui Hui Liu; Wei Xia Chen; Man Man Niu; Qi Jiang; Zhen Qiu; Guo Zhen Fan; Rui Xue Li; Goshgar Mammadov; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Peng Hu
Journal:  Pediatr Res       Date:  2021-09-28       Impact factor: 3.953

Review 4.  Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndrome.

Authors:  Deniz Yeter; Richard Deth; Ho-Chang Kuo
Journal:  Korean Circ J       Date:  2013-09       Impact factor: 3.243

5.  Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children.

Authors:  Na Hyun Lee; Hee Joung Choi; Yeo Hyang Kim
Journal:  Korean J Pediatr       Date:  2017-04-25

6.  Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.

Authors:  Shuran Shao; Chunyan Luo; Kaiyu Zhou; Yimin Hua; Mei Wu; Lei Liu; Xiaoliang Liu; Chuan Wang
Journal:  Pediatr Rheumatol Online J       Date:  2019-11-27       Impact factor: 3.054

Review 7.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

8.  A new model to predict intravenous immunoglobin-resistant Kawasaki disease.

Authors:  Wang Hua; Yameng Sun; Ying Wang; Songling Fu; Wei Wang; Chunhong Xie; Yiying Zhang; Fangqi Gong
Journal:  Oncotarget       Date:  2017-09-19

9.  Analysis of the Risk Factors in Prognosis of Kawasaki Disease With Coronary Artery Lesions.

Authors:  Jinling Hu; Weidong Ren
Journal:  Front Pediatr       Date:  2021-12-07       Impact factor: 3.418
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.